评估与处方相关的阿片类药物使用障碍所致的工作损失：基于索赔数据的回顾性分析。

Assessment of Work Loss Associated With Prescription-Related Opioid Use Disorder: A Retrospective Analysis of Claims Data.

机构信息

Analysis Group, Inc. Boston, Massachusetts (Dr White, Mr Spittle, Ms Fernan, Ms Billmyer); Daiichi Sankyo, Inc. Basking Ridge, New Jersey (Ms Marrett, Dr Kwong); and The College of William and Mary, Williamsburg, Virginia (Dr Rossiter).

出版信息

J Occup Environ Med. 2020 Mar;62(3):217-222. doi: 10.1097/JOM.0000000000001802.

DOI:10.1097/JOM.0000000000001802

PMID:32134845

Abstract

OBJECTIVE

Quantify work loss and costs associated with prescription opioid use disorder (OUD) from the employer perspective.

METHODS

Retrospective claims analysis to compare missed work days and associated costs between employees with and without an OUD diagnosis in a 12-month period.

RESULTS

Two thousand three hundred eleven matched-pairs of employees were compared. The mean (SD) number of days missed while waiting for disability benefits (0.24 [1.4] vs 0.17 [1.0]; P = 0.035), absenteeism due to disability claims (9.5 [40.9] vs 5.6 [30.0]; P < 0.001), and medical visits (17.8 [18.5] vs 10.0 [12.4]; P < 0.001) was higher for employees with OUD compared with those without, resulting in higher mean (SD) indirect cost estimates of $8193 ($14,694) per employee (OUD) versus $5438 ($13,683) per employee (no OUD) (P < 0.001).

CONCLUSIONS

Prescription OUD is associated with significant work loss and may pose considerable economic burden on employers.

摘要

目的

从雇主角度量化与处方类阿片使用障碍（OUD）相关的工作损失和成本。

方法

回顾性理赔分析比较了在 12 个月期间患有和不患有 OUD 诊断的员工的旷工天数和相关成本。

结果

比较了 2311 对匹配的员工。在等待残疾津贴期间缺勤的平均（SD）天数（0.24 [1.4] vs 0.17 [1.0]；P=0.035）、因残疾索赔而缺勤的天数（9.5 [40.9] vs 5.6 [30.0]；P<0.001）和医疗就诊次数（17.8 [18.5] vs 10.0 [12.4]；P<0.001），患有 OUD 的员工高于不患有 OUD 的员工，导致每名员工的间接成本估计值（OUD 员工为 8193 美元（14694 美元），无 OUD 员工为 5438 美元（13683 美元））更高（P<0.001）。